BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29626303)

  • 1. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
    Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
    Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
    Kantor O; Means J; Grossmith S; Dey T; Bellon JR; Mittendorf EA; King TA
    Ann Surg Oncol; 2022 Feb; 29(2):972-980. PubMed ID: 34467507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.
    Grossmith S; Nguyen A; Hu J; Plichta JK; Nakhlis F; Cutone L; Dominici L; Golshan M; Duggan M; Carter K; Rhei E; Barbie T; Calvillo K; Nimbkar S; Bellon J; Wong J; Punglia R; Barry W; King TA
    Ann Surg Oncol; 2018 Nov; 25(12):3527-3534. PubMed ID: 29868979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.
    Moossdorff M; Nakhlis F; Hu J; Barry WT; Losk K; Haskett C; Smidt ML; King TA
    Ann Surg Oncol; 2018 Sep; 25(9):2612-2619. PubMed ID: 29855827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy.
    Picado O; Khazeni K; Allen C; Yakoub D; Avisar E; Kesmodel SB
    Breast Cancer Res Treat; 2018 Sep; 171(2):461-469. PubMed ID: 29869773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
    Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
    Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
    Johnson J; Esserman L; Ewing C; Alvarado M; Park C; Fowble B
    Ann Surg Oncol; 2016 Mar; 23(3):715-21. PubMed ID: 26714943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.
    Weiss A; Lin H; Babiera GV; Bedrosian I; Shaitelman SF; Shen Y; Kuerer HM; Mittendorf EA; Caudle AS; Hunt KK; Hwang RF
    Breast Cancer Res Treat; 2019 Jul; 176(2):435-444. PubMed ID: 31025270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
    Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
    Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Mamtani A; Patil S; Stempel M; Morrow M
    Ann Surg Oncol; 2017 Aug; 24(8):2182-2188. PubMed ID: 28429197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.
    Stauder MC; Caudle AS; Allen PK; Shaitelman SF; Smith BD; Hoffman KE; Buchholz TA; Chavez-Macgregor M; Hunt KK; Meric-Bernstam F; Woodward WA
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):637-44. PubMed ID: 27681760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer.
    Yao K; Liederbach E; Pesce C; Wang CH; Winchester DJ
    J Am Coll Surg; 2015 Jul; 221(1):71-81. PubMed ID: 25899731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
    Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
    Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel node biopsy in early breast cancer: lessons learned from more than 1000 cases at a single institution.
    Fancellu A; Cottu P; Feo CF; Bertulu D; Giuliani G; Mulas S; Sanna V; Mura S; Madeddu G; Spanu A
    Tumori; 2012; 98(4):413-20. PubMed ID: 23052155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study.
    Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
    Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
    Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes.
    Joo JH; Kim SS; Son BH; Ahn SD; Jung JH; Choi EK; Ahn SH; Lee JW; Kim HJ; Ko BS
    Cancer Res Treat; 2019 Jul; 51(3):1011-1021. PubMed ID: 30322228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
    Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
    Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy.
    Lim SZ; Kusumawidjaja G; Mohd Ishak HM; Tan BKT; Tan SY; Hamzah JL; Madhukumar P; Yong WS; Wong CY; Sim Y; Lim GH; Lim SH; Tan SM; Wong FY; Tan VKM
    Breast Cancer Res Treat; 2021 Oct; 189(3):837-843. PubMed ID: 34342766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.